Cargando…
UCP-2 inhibitor enhanced the efficacy of trastuzumab against HER2 positive breast cancer cells
PURPOSE: This study aimed to investigate the possibility of UCP-2 inhibitor in reducing acquired resistance of trastuzumab to improve the outcome of patients receiving trastuzumab therapy by exploring the relationship between UCP-2 expression and HER2 signaling pathway and examining whether UCP-2 ex...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Berlin Heidelberg
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8367901/ https://www.ncbi.nlm.nih.gov/pubmed/34146128 http://dx.doi.org/10.1007/s00280-021-04303-4 |